Hill-Rom Holdings Inc (HRC) Holdings Cut by LSV Asset Management

LSV Asset Management lowered its holdings in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 20.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 572,500 shares of the medical technology company’s stock after selling 151,246 shares during the quarter. LSV Asset Management owned approximately 0.87% of Hill-Rom Holdings worth $45,576,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of HRC. Strs Ohio purchased a new position in Hill-Rom Holdings during the first quarter worth approximately $1,765,000. Russell Investments Group Ltd. boosted its position in Hill-Rom Holdings by 64.3% during the first quarter. Russell Investments Group Ltd. now owns 62,568 shares of the medical technology company’s stock worth $4,418,000 after purchasing an additional 24,477 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in Hill-Rom Holdings by 1.5% during the first quarter. Oregon Public Employees Retirement Fund now owns 20,913 shares of the medical technology company’s stock worth $1,476,000 after purchasing an additional 300 shares in the last quarter. Wells Fargo & Company MN boosted its position in Hill-Rom Holdings by 6.9% during the first quarter. Wells Fargo & Company MN now owns 71,499 shares of the medical technology company’s stock worth $5,047,000 after purchasing an additional 4,619 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its position in Hill-Rom Holdings by 457.1% during the first quarter. Canada Pension Plan Investment Board now owns 11,700 shares of the medical technology company’s stock worth $826,000 after purchasing an additional 9,600 shares in the last quarter. Institutional investors own 82.31% of the company’s stock.

Hill-Rom Holdings Inc (NYSE:HRC) opened at 77.42 on Friday. Hill-Rom Holdings Inc has a 52-week low of $50.50 and a 52-week high of $84.65. The stock has a market cap of $5.10 billion, a P/E ratio of 45.12 and a beta of 1.21. The stock has a 50 day moving average price of $76.07 and a 200 day moving average price of $74.71.

Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company had revenue of $689.10 million for the quarter, compared to analysts’ expectations of $695.50 million. During the same quarter in the previous year, the firm posted $0.81 EPS. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. On average, equities research analysts forecast that Hill-Rom Holdings Inc will post $3.82 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s payout ratio is 41.62%.

A number of brokerages have issued reports on HRC. BidaskClub downgraded Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Zacks Investment Research downgraded Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Needham & Company LLC lowered their price target on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research report on Friday, July 28th. Barclays PLC increased their price target on Hill-Rom Holdings from $80.00 to $86.00 and gave the stock an “overweight” rating in a research report on Friday, June 9th. Finally, Cantor Fitzgerald began coverage on Hill-Rom Holdings in a research report on Thursday, June 29th. They set a “neutral” rating and a $86.00 price target on the stock. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $88.17.

WARNING: “Hill-Rom Holdings Inc (HRC) Holdings Cut by LSV Asset Management” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://sportsperspectives.com/2017/09/10/hill-rom-holdings-inc-hrc-holdings-cut-by-lsv-asset-management.html.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply